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Transcriptional regulation by nuclear receptors occurs through complex interactions that involve DNA response
elements, co-activators/co-repressors, and histone modifying enzymes. Very little is known about how molecular
interplay of these components may determine tissue speciﬁcity of hormone action. We have shown previously that
retinoic acid (RA) and thyroid hormone (T3) repress transcription of a specific group of epidermal keratin genes
through a novel mechanism that utilizes receptors homodimers. In this paper, we have analyzed the epidermal
speciﬁcity of RA/T3 action by testing the role of co-repressors and co-activators in regulation of epidermal genes.
Using transient co-transfections, northern blots, antisense oligonucleotides, and a histone deacetylase (HDAC)
inhibitor, trichostatin A, we found that in the context of specific keratin RE (KRE), co-activators and histone
acetylase become co-repressors of the RA/T3 receptors in the presence of their respective ligands. Conversely, co-
repressors and HDAC become co-activators of unliganded T3Ra. The receptor–co-activator interaction is intact and
occurs through the NR-box. Therefore, the role of co-activator is to associate with liganded receptors whereas the
KRE–receptor interaction determines specific transcriptional signal, in this case repression. This novel molecular
mechanism of transcriptional repression conveys how RA and T3 target specific groups of epidermal genes, thus
exerting intrinsic tissue speciﬁcity.
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Retinoic acid (RA) and thyroid hormone (T3) are important
regulators of development, differentiation, and gene ex-
pression in many tissues, including the epidermis (Stell-
mach et al, 1991; Rosenthal et al, 1992; Fisher et al, 1995;
Blumenberg, 1996; Fisher and Voorhees, 1996). The pro-
found effects of retinoids on the epidermis have been
known for more than 70 years (reviewed in Fisher et al,
1995). Both in vivo and in vitro, RA deficiency causes
hyperkeratosis and promotes differentiation of epidermal
keratinocytes, whereas an excess of RA prevents ‘‘keratin-
ization’’ and keeps keratinocytes in a basal layer-like phe-
notype (Gilfix and Eckert, 1985; Lichti et al, 1985; Magnaldo
et al, 1992). Retinoids are also used in the treatment of
a large number of epidermal disorders ranging from
ichthyoses to skin cancers (Epstein, 1981; Fisher et al,
1991; Kraemer et al, 1992; Steijlen et al, 1993; Futoryan and
Gilchrest, 1994; Moon et al, 1995; Lotan, 1996). In addition,
hypothyroidism causes numerous epidermal changes
including scaly, dry, hyperkeratotic skin, eczema, and
ichthyosis. Similarly, T3 deficiency in vitro results in in-
creased expression of late differentiation markers (Holt and
Marks, 1977; Rosenberg et al, 1986; Isseroff et al, 1989;
Heymann, 1997). Topical T3 application stimulates prolifer-
ation, whereas it also stimulates proliferation inhibitory fac-
tor(s) in the skin (Safer et al, 2003).
RA and T3 mediate their effects through binding to spe-
cific nuclear receptors (NR), proteins that, on one hand,
bind their ligand and, on the other, bind DNA at specific
sites in the vicinity of regulated genes. Once bound to the
DNA, the receptors interact with co-regulators and the
transcriptional machinery to regulate transcription (Mange-
lsdorf et al, 1995; Fondell et al, 1996; Vom Baur et al, 1996;
Hong et al, 1997; Gronemeyer and Miturski, 2001).
There are two possible pathways that lead to either re-
pression or enhancement of transcription by NR, depending
on the presence or absence of the ligand on the receptor.
In the first pathway, the liganded receptor binds to the
response element (RE) and recruits a group of proteins
called co-activators (such as NCoA, SRC-1, or GRIP-1),
Abbreviations: CAT, chloramphenicol acetyl transferase; DR-4, a
direct repeat of consensus sequence spaced by four nucleotides;
EGF, epidermal growth factor; GH, growth hormone; HAT, histone
acetylase; HDAC, histone deacetylase; KRE, keratin response el-
ement; NFkB, nuclear factor kB; NR, nuclear receptor; RA, retinoic
acid; RAR, retinoic acid receptor; RARE, retinoic acid response
element; RE, response element; T3, thyroid hormone; T3R, thyroid
hormone receptor; TRE, thyroid hormone response element; TSA,
trichostatin A
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which interact with other co-integrators (p-CIP, CBP/p300)
that bind histone acetylase (HAT), leading to the induction of
transcription (Heinzel et al, 1997; Montminy, 1997; Nagy
et al, 1997; Spencer et al, 1997; Torchia et al, 1997). In
addition, CBP and p300 have the activity of a HAT and can
induce transcription without further interaction with HAT
(Ogryzko et al, 1996; Torchia et al, 1997). Conversely, the
unliganded receptor binds to the RE and recruits a co-re-
pressor (such as NCoR or SMRT), which then interacts with
co-integrator proteins (such as mSin3A). The co-integrator
binds to histone deacetylase (HDAC), leading to repression
of transcription. Most co-regulators are found to be pro-
miscuously expressed and seem to participate in many
transcriptional pathways in addition to those involving NR
(Khan and Nawaz, 2003).
One of the central questions is what determines the
specificity of particular transcriptional regulation: how is the
specificity of the regulation directed to a tissue and, further,
to specific genes? To extrapolate this question to skin: how
is this general system tailored to suit the purpose of epi-
dermal physiology and epidermal gene expression? The
complexity of transcriptional regulation depends on the se-
lection of the appropriate combination of DNA RE and in-
teracting transcription factors. Combined, they select, by
resuming appropriate conformation, a particular group of
co-regulators that mediate the signal to the transcriptional
machinery. Therefore, the diversity and potential of the
transcriptional regulation is limited by the number of pos-
sible combinations of numerous interacting factors (McKen-
na et al, 1999).
We have shown previously that RA, T3, and glucocorti-
coids (GC) regulate epidermal keratin genes though unique
molecular mechanisms. Retinoic acid receptor (RAR) and
T3R homodimers and four monomers of glucocorticoid re-
ceptor (GR), in the presence of their respective ligands,
mediate repression of specific, disease-associated, epider-
mal keratin genes: K5, K14, K6, K16, and K17 (Tomic-Canic
et al, 1992; Radoja et al, 1997; Lee et al, 2004). Furthermore,
these three receptors all bind to the specific keratin RE
(KRE) that are highly conserved among the regulated group
of keratin promoters and it is the structure of the KRE that
determines the specific receptor configuration and medi-
ates the signal for repression.
Knowledge about co-regulators has been obtained from
reporter genes that are either induced by liganded receptors
or repressed by unliganded receptors. Very little is known
about the function of these proteins in repression of tran-
scription mediated by liganded receptors and activation
mediated by unliganded receptors. Therefore, we used a
family of genes that are negatively regulated by RA and T3
to answer directly the important questions of which co-reg-
ulators are specific for the regulation of keratin gene ex-
pression by liganded RAR and T3R; what is the mechanism
involving those co-regulators and what is the role of the
histone acetylation/deacetylation in this process? We found
that co-activators act as co-repressors of liganded RAR and
T3R in the context of KRE. Conversely, we found that co-
repressors become co-activators of unliganded T3R in the
context of the KRE. Furthermore, we also found that a HAT,
CBP participates in repression, whereas HDAC participates
in activation of keratin gene expression. Taken together, we
conclude that the interaction between co-regulators and the
appropriate receptors (liganded vs unliganded) is consistent
and does not seem to depend on specific RE; however, it is
the RE that probably initiate the transcriptional output. The
liganded receptor interacts with a co-activator and in the
case of a consensus element the signal enhances tran-
scription, whereas in the case of KRE the signal is opposite
and leads to repression.
Results
To establish the role of the co-regulators in transcriptional
regulation of genes in the epidermis, we have used co-
transfection experiments and tested how specific co-regu-
lators affect regulation of keratin gene expression by RA
and T3 receptors. We have shown previously that these
epidermal genes are suppressed by RAR and T3R ho-
modimers and therefore, we tested first common co-re-
pressors: NCoR and SMRT. Interestingly, we found that
NCoR and SMRT had no effect. Neither of the two co-re-
pressors affected suppression of K5, K14, and K17 pro-
moters by either RAR or T3R in the presence of their ligands
(Fig 1). Both positive controls, a direct repeat of consensus
sequence spaced by four nucleotides (DR-4) (containing
consensus TRE) and retinoic acid response element (RARE)
(containing consensus RARE) were induced by RAR and
T3R in the presence of their ligands and, as expected,
NCoR and SMRT did not significantly affect their activation
(Fig 1). To confirm proper NCoR and SMRT activity in our
experimental system, we tested their activity in the pres-
ence of unliganded T3R (Fig 2A). As expected, both NCoR
and SMRT acted as co-repressors of the T3R in the ab-
sence of its ligand in the regulation of positive control, DR-4.
We found that both NCoR and SMRT enhanced the activa-
tion of K5, K14, and K17 by the unliganded T3R, suggesting
that in the context of these specific KRE they act as co-
activators rather than co-repressors (Fig 2A). To further
confirm this, we tested their activity in the presence of con-
stitutive repressor, v-erbA receptor, a T3R mutant unable to
bind its ligand (Tomic-Canic et al, 1996). As expected,
NCoR and SMRT enhanced repression of DR-4 by the v-
erbA (Fig 2B). Consistent with our initial findings, both NCoR
and SMRT enhanced v-erbA-mediated activation of K5,
K14, and K17 promoters, thus confirming that they are
indeed co-activators in the context of these promoters
(Fig 2B).
If the co-repressors behave as co-activators, the logical
question is how co-activators behave in the context of KRE.
To establish the role of co-activators, we tested NCoA and
GRIP-1 in co-transfection experiments. Interestingly, we
found that both enhanced suppression of K5, K14, and K17
promoters by RAR and T3R in the presence of their re-
spective ligands. As expected, they enhanced activation of
DR-4 and RARE controls by liganded T3R and RAR (Fig 3A).
Therefore, we conclude that NCoA and GRIP-1 act as co-
repressors in the context of KRE. To test how the receptor
and co-regulator interact in the context of a KRE, we used
the GRIP-1 NR box mutant in co-transfection experiments.
The GRIP-1 NR box mutant carries a mutation in the region
responsible for interaction with the receptor (NR box) and is
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Figure 1
Co-repressors NCoR and SMRT do not
participate in repression of keratin
genes by retinoic acid (RA) and thyroid
hormone (T3). Effects of co-transfection
of NCoR and SMRT on keratin gene ex-
pression in the presence of the T3 and
thyroid hormone receptor a (T3R) is
shown on the top left graph. There is no
change either on the basic promoter ac-
tivity or on the repression of keratin genes
by T3 in the presence of co-repressors.
As expected, NCoR and SMRT did not
have any effect on a positive control, DR-
4, in the presence of the liganded T3R
(top right). Similarly, NCoR and SMRT did
not significantly affect repression of kera-
tin promoters by retinoic acid receptor
(RAR) in the presence of RA (bottom left
panel). As expected, the activation of re-
tinoic acid response element (RARE) was
not affected by NCoR and SMRT (bottom
right).
Figure 2
Co-repressors NCoR and SMRT be-
come co-activators of unliganded thy-
roid hormone receptor a (T3R) in the
context of keratin promoters. (A) NCoR
and SMRT enhanced the activation of
keratin promoters by unliganded T3R 2-
fold in co-transfection experiments (left),
thus acting as co-activators. As expected,
NCoR and SMRT enhanced repression
of a positive control, a direct repeat of
consensus sequence spaced by four nuc-
leotides (DR-4), thus acting as co-repres-
sors. (B) NCoR and SMRT were co-re-
pressors of v-erbA receptor (a mutant T3R
receptor unable to bind its ligand) in re-
pression of keratin promoters (left) where-
as they were co-repressors of v-erbA in
repression of DR-4 (right).
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unable to bind the receptor through this site. We found that
the mutation in the NR box was sufficient to abolish the co-
repressive function of GRIP-1, as GRIP-1 NR box mutant
had no effect on suppression by either liganded RAR or T3R
(Fig 3B). This suggests that the interaction between the NR
and co-activator occurs through a common site in the con-
text of KRE and is not affected by the KRE.
If a co-activator becomes a co-repressor in the context
of the KRE, the question is do they further interact with
HDAC or HAT? To further test the role of HAT in repression
of keratin genes, we tested CBP. We used four different
concentrations of CBP: 0.3, 1, 3, and 9 mg, whereas the
receptor amount was kept constant. We found that CBP
acted as a repressor by enhancing the repression of the K14
promoter by liganded T3R and RAR in a concentration-de-
pendent manner (Fig 4). The highest dose decreased the
basic activity of the promoter. Furthermore, we tested the
effect of the small dose of 0.3 mg of CBP on two different
amounts of the receptor: 0.5 and 1 mg. We found that CBP
enhanced repression of K14 by liganded RAR in a receptor
concentration-dependent manner (Fig 5A). We also found
that it had similar effects on liganded T3R—it enhanced its
repression of K14 promoter (Fig 5B). Thus, CBP also be-
haves as a co-repressor of liganded RAR and T3R. In-
terestingly, we found that it reduced the activation of
unliganded T3R when 1 mg of the receptor was used (Fig
5C). This indicates the possible squelching of endogenous
co-activators. CBP is known to interact with co-activators
Figure 3
Co-activators, GRIP and NCoA become
co-repressors of thyroid hormone re-
ceptor a (T3R) and retinoic acid re-
ceptor (RAR) in the presence of their
ligands. (A) GRIP and NCoA enhance re-
pression of keratin promoters mediated
by the T3R in the presence of the T3 (top
left) and RAR in the presence of retinoic
acid (RA) (bottom left). As expected, GRIP
and NCoA enhance activation of positive
controls DR-4 (a direct repeat of consen-
sus sequence spaced by four nucleo-
tides) by T3R in the presence of T3 (top
right) and RARE by RAR in the presence
of RA (bottom right). (B) In a contrast to
GRIP wild-type, a GRIP mutant unable to
bind nuclear receptors, GRIP nuclear re-
ceptor (NR) mut, did not affect repression
of keratin promoter by RAR and T3R re-
ceptors in the presence of their respective
ligands.
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and in this context it may preclude their binding to un-
liganded T3R, which may further lower the level of K14
promoter activation.
Taken together, our results suggest that co-activators act
as co-repressors and co-repressors act as co-activators in
the context of keratin gene promoters. All results described
above were, however, obtained from co-transfection of the
expression plasmids, i.e., an exogenous source of the co-
regulators. To block the endogenous NCoR, SMRT, and
NCoA, we used antisense technology. The oligonucleotides
were designed to bind the initiation codon and the se-
quences immediately upstream of human SMRT, NcoR, and
NCoA. They were synthesized as phosphorothioates and
added both to the DNA transfection mixture and subse-
quently to the medium. As a control for non-specific anti-
sense oligonucleotide effects, we have used a nuclear
factor kB (NFkB) antisense oligonucleotide (AS-NFkB),
which should not affect keratin regulation by RAR/T3R.
We chose AS-NFkB because it has been reported to suc-
cessfully block, specifically, another transcription factor,
NFkB (Reuning et al, 1995). We used GH-TRE as a positive
control, because this RE originates from the growth hor-
mone (GH) gene, i.e., a native promoter that is induced by
RAR and T3R. We found that AS-SMRTand AS-NCoR block
the activation of keratin genes by unliganded T3R, whereas
they block the suppression of GH-TRE. Conversely, AS-
NCoA blocks the ligand-mediated suppression of keratin
gene expression by both RAR and T3R, whereas it blocks
the induction of GH-TRE (Fig 6A). AS-NFkB had no effect,
although it specifically blocked the NFkB mediated regula-
tion of NFkB-CAT (Fig 6B), a well-characterized positive-
response construct (Vietor et al, 1996). Furthermore, co-
transfection of exogenous cDNA of NCoR partially over-
comes the block of regulation by AS-NCoR, whereas co-
transfection of NCoA cDNA partially overcomes the block of
regulation by AS-NCoA (data not shown). Taken together, all
these results indicate that that SMRT and NCoR are co-
activators, whereas NCoA is a co-repressor of keratin gene
regulation by RAR/T3R. Furthermore, a HAT, CBP also acts
as a co-repressor in the presence of the liganded receptors,
suggesting that it also participates in repression. Converse-
ly, co-repressors act as co-activators of unliganded recep-
tors. This raises the question of the role of HDAC in the
context of keratin genes. To test the role of HDAC, we used
trichostatin A (TSA), a specific inhibitor of HDAC (Garcia-
Villalba et al, 1997; Jenster et al, 1997; Wong et al, 1997).
If co-activators and HAT participate in repression and co-
Figure 4
CBP also becomes a co-repressor of liganded thyroid hormone
receptor a (T3R) and retinoic acid receptor (RAR) in the context of
keratin promoters. CBP, in a concentration-dependent manner, en-
hanced repression of K14 keratin promoter by T3R and RAR in the
presence of their ligands (top panel). It enhanced activation of a pos-
itive control TRE/retinoic acid response element (RARE) (bottom panel).
Figure5
Co-repression of CBP is consistent with different receptor con-
centrations. The effects of a small dose of CBP (0.3 mg) were tested
with increasing amounts of the receptors. (A) CBP enhanced repression
of K14 by liganded retinoic acid receptor (RAR) in the receptor con-
centration-dependent manner. (B) Similarly, CBP enhanced repression
of K14 by liganded thyroid hormone receptor a (T3R). (C) CBP reduced
the activation of unliganded T3R when 1 mg of the receptor was used.
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repressors participate in activation, one may speculate that
HDAC may participate in the activation of keratin genes. We
tested two different concentrations of HDAC inhibitor, TSA,
107 M and 108 M. If our hypothesis is correct (HDAC
participates in activation), we would expect that HDAC in-
hibitor blocks the activation by the unliganded T3R and
does not affect the repression by the T3R in the presence of
its ligand. This is exactly what we found. Both concentra-
tions of TSA blocked the induction by unliganded T3R, but
did not affect the regulation by liganded receptors (Fig 7;
see also Fig 8).
Lastly, to confirm our results at the level of the endog-
enous keratin genes, we tested K14 messenger RNA (mRNA)
levels using northern blot analyses. To test the effects of co-
activator GRIP-1, we transfected keratinocytes with the ex-
pression plasmid-containing GRIP-1 cDNA and incubated
them in the presence or absence of either T3RþT3 (Fig 8A)
or RARþRA (Fig 8B) and measured the changes in K14
mRNA levels using northern blot. As expected, we found that
GRIP-1 indeed enhanced repression of K14 mRNA by both
T3 and RA and their corresponding receptors. The levels of
co-repression are perhaps not as high as in co-transfection
experiments, as we anticipated. We believe that this differ-
ence originates from the background created by the cells
that did not receive the transfected expression vector. Fur-
thermore, we also tested the effects of the inhibitor of HDAC,
TSA, in the presence of T3 and RA and found that the re-
pression of K14 mRNA is maintained even when HDAC is
inhibited (Fig 8). Taken together, our results have shown that
the induction of keratin gene expression by the unliganded
T3R involves NCoR and HDAC, whereas the suppression by
the liganded T3R and RAR involves NCoA and CBP.
Discussion
Cooperative interactions of multicomponent transcriptional
complexes are known to initiate and maintain many biolog-
ical processes. Mechanisms for their tissue specificity,
Figure 6
Co-activation by SMRT and NCoR as well as co-repression by
NCoA can be blocked by specific antisense oligonucleotides. Spe-
cific oligonucleotides targeting the initiation codon and the sequences
immediately upstream of human SMRT, NcoR, and NCoA were used in
co-transfection experiments. AS-SMRT and AS-NCoR block the acti-
vation of keratin genes by unliganded thyroid hormone receptor (T3R),
whereas they block the suppression of GH-TRE (a positive control
containing native TRE from growth hormone (GH) promoter). Con-
versely, AS-NCoA blocks the ligand-mediated suppression of keratin
gene expression by both retinoic acid receptor (RAR) and T3R, whereas
it blocks the induction of GH-TRE. As a control for non-specific an-
tisense oligonucleotide, we have used the nuclear factor kB (NFkB)
antisense oligonucleotide (AS-NFkB), which should not affect keratin
regulation by RAR/T3R. As expected, AS-NFkB had no effect (B).
Control for antisense oligonucleotides. AS-NFkB specifically blocked
the NFkB-mediated regulation of (NFkB)3-CAT. Co-transfection of ex-
pression plasmids containing NFkB-enhanced (NFkB)3-CAT.
Figure7
Histone deacetylation is contributing to activation of keratin gene
transcription by unliganded thyroid hormone receptor a (T3R).
Trichostatin A (TSA), a specific inhibitor of histone deacetylase, blocked
the induction by unliganded T3R, but did not affect the regulation
by liganded receptors in the context of keratin K14 promoters. TSA
blocked repression of DR-4 (a direct repeat of consensus sequence
spaced by four nucleotides) by unliganded T3R whereas the activation
by liganded receptor was not affected. Two different concentrations
were used, 107 M and 108 M, and both had a similar effect.
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however, are not well understood. In this paper, we show
how various co-regulators whereas mediators of hormone
signaling target specific epidermal genes. We found that in
the context of epidermal keratin genes, NR co-activators
become co-repressors, and vice versa (Fig 9). These find-
ings are important because they change the current para-
digm of the role of co-activators and co-repressors. Their
function is to associate with a particular configuration of the
receptor, determined by the DNA and the presence of the
ligand. The ‘‘producers’’ of the signal for transcriptional
regulation are the DNA and the receptor. Co-regulators,
however, are necessary for transmitting that signal. Several
important points derive from these findings. First, these re-
sults are consistent with our previous findings (Radoja et al,
1997, 2000; Jho et al, 2001) and they reinforce the proposed
model of the DNA as a specific ‘‘ligand for a receptor’’ (Pe-
arce et al, 1998; Yamamoto et al, 1998; Van Tilborg et al,
2000; Claessens et al, 2001). It is interesting that none of the
co-regulators we have tested affect the KRE in the way
initially described for the positive RE (Fig 9). The specific
details of molecular interaction between these components
within this KRE-specific complex remain to be elucidated
and are the subject of these experiments. The results pre-
sented with various co-regulators, however, emphasize the
point that regulation of keratin gene expression by NR oc-
curs through a specific, novel mechanism.
The question remains of how the DNA–receptor interac-
tion determines whether a gene will be induced or re-
pressed. We believe that the sequence of the KRE, by
determining the receptor configuration(s), homodimer ver-
sus heterodimer, or monomer versus heterodimer, plays a
crucial role in such signaling. Interestingly, we found that the
GR, which also targets the same epidermal promoters,
binds in a unique four monomer formation (Radoja et al,
2000) and as such does not interact with either co-activa-
tors or co-repressors that RAR/T3R interact with in the
context of KRE (Radoja et al, 2000; Lee et al, 2004).1 This
supports the notion that DNA determines the receptor con-
figuration that further transmits the appropriate transcrip-
tional signal. Lastly, in this context, we found that GR
dominates over RAR and T3R in the transcriptional regula-
tion of epidermal keratin genes (Jho et al, 2001; Lee et al,
2004).
Another intriguing question of how HAT participates in
the repression and how HDAC can participate in the induc-
Figure 8
Endogenous K14 repression by thyroid hormone receptor a (T3)
and retinoic acid (RA) is enhanced by co-activator GRIP-1 and oc-
curs in the presence of histone deacetylase (HDAC) inhibitor Tric-
hostatin A (TSA). Northern blots with messenger RNA isolated from
primary human keratinocytes transfected with co-activator GRIP-1 or
incubated in the presence or absence of TSA. (A) Regulation by T3R in
the presence of thyroid hormone (T3); (B) regulation by RARg in the
presence of RA. K14 is repressed by both T3 and RA, and this repres-
sion is enhanced in the presence of GRIP-1, thus confirming that GRIP-
1 participates in repression. Furthermore, the repression is maintained
in the presence of HDAC inhibitor TSA, confirming that HDAC does not
participate in this repression.
Figure9
The summary of the keratin specific regulatory pathway. (A) A car-
toon summary of the nuclear receptor regulatory pattern described for
consensus, positive element is shown. These elements convey activa-
tion of transcription by heterodimers of receptors in the presence of
their ligands and co-activators whereas they are repressed by un-
liganded receptors and co-repressors. (B) Our data indicate that the
keratin response elements (KRE) convey repression by homodimers of
receptors, and in this context of the DNA and receptor configuration,
the co-activators become co-repressors of liganded retinoic acid re-
ceptor (RAR) and thyroid hormone receptor (T3R). Conversely, KRE
convey activation by unliganded receptors, and in such a context, co-
repressors become co-activators of unliganded T3R.The question mark
indicates that further analyses are necessary to confirm the involve-
ment of mSin3A and specific HDAC in co-activation by unliganded T3R.
1Stojadinovic et al, submitted.
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tion of transcription. Although the mechanisms are not well
understood, there are several reports in the literature that
indicate such possibilities. For example, HAT activity was
found to play an important role in the repression of ARG1
gene transcription and a decrease in the level of acetylated
histones at the ARG1 promoter correlated with increased
ARG1 expression (Ricci et al, 2002). Furthermore, a func-
tional coordination between the promoter and enhancer
through shared co-activators in the androgen receptor tran-
scription complex discriminates between activation and
repression. This means that there is a distinct function of
co-activator complexes determined by their binding to two
different DNA segments—a repression complex involves
factors bound only at the promoter and not the enhancer,
whereas formation of an activation complex involves AR, co-
activators, and RNA polymerase II recruitment to both the
enhancer and promoter (Shang et al, 2002). Conversely, it
has also been shown that co-repressors may participate in
the transcriptional activation. For example, the presence of
N-CoR can enhance TR-b-mediated transcriptional activa-
tion (Li et al, 2002). HDAC also play a role in transcriptional
activation of certain endogenous CREB target genes (Fass
et al, 2003). Lastly, recent findings showed that HDAC plays
a crucial role in interferon-stimulated transcriptional activa-
tion (Chang et al, 2004; Klampfer et al, 2004; Sakamoto et al,
2004). Taken together, the exact mechanisms through which
HAT participate in transcriptional repression and HDAC in
activation remains to be elucidated. However, examples of
such activities in the specific promoter contexts or particular
conditions support our finding that the complexes targeting a
specific group of epidermal genes in which co-activators and
HAT participate in repression, and co-repressors and HDAC
participate in activation of transcription, is an excellent ex-
ample of tissue specificity of hormone action.
The question is how these regulatory mechanisms affect
epidermal biology, i.e., what is their role in the context of
epidermal function? Epidermal keratins are important par-
ticipants of epidermal function and are often used as mark-
ers of particular keratinocyte pathways. Therefore, their
expression is tightly controlled by multiple mechanisms. For
example, K6/K16/K17, hallmarks of the activated keratin-
ocyte phenotype can be induced by epidermal growth
factor (EGF)/transforming growth factor (TGF)-a, tumor
necrosis factor-a (THF-a), interleukin-1 (IL-1) and interferon
(IFN)-g, all of which activate their transcription. Similarly, K5/
K14, hallmarks of basal keratinocytes, are activated by
TGF-b. As we presented in this paper, these promoters are
repressed by liganded RAR and T3R complexed with co-
activators. All these hormones, growth factors and cyto-
kines act in concert to provide epidermal homeostasis. This
means that under certain physiological conditions, such as
during wound healing, they are not only simultaneously
present, but may also target epidermal keratin genes at the
same time. In such situations, they may either compete for
the co-activators or perhaps share them. We have recently
shown that when both EGF and RA are present simultane-
ously, the level of expression of K6/K16 is intermediate; a
product of both signals (Lee et al, 2004). Similar co-dom-
inant effects were found on K5/K14 and K17 keratin genes
using IFN-g, TGF-b, and thyroid hormone signaling mole-
cules. These co-dominant effects are specific only for genes
that are regulated by both pathways (Tomic-Canic et al,
1996). We have shown that the lack of a single copy of one
NR co-activator (NRC-1) disturbs epidermal homeostasis,
impairs EGF response and leads to a defect in epidermal
wound repair and to the development of chronic wounds
(Mahajan et al, 2004). Taken together, our results suggest
that endogenous levels of all components may play a cru-
cial role in determining the level of particular keratin gene
activity. Furthermore, such complex molecular mechanisms
may provide very refined tuning of gene dosages that may
be fundamental for epidermal functions. For example, it has
been shown that either excess or lack of K6 may cause
similar effects on keratinocyte migration, suggesting that a
particular amount of K6/K16 allows for cytoskeleton flexi-
bility and provides for adequate migration capabilities (Cou-
lombe and Omary, 2002; Wong and Coulombe, 2003). In
this context, fine transcriptional tuning of keratin genes may
be accomplished through the concerted effort of growth
factors/cytokines (induction) and hormones/vitamins (re-
pression) made possible by the molecular mechanisms we
presented in this paper. Lastly, these results emphasize the
need for understanding such tissue and context-specific
transcriptional regulation, especially when new therapeutic
modalities for various skin disorders are being developed.
Materials and Methods
Plasmids, their growth and puriﬁcation Plasmids pK14CAT,
pK5CAT, pK17, RAR, T3R, and v-erbA have been described pre-
viously (Tomic-Canic et al, 1992; Radoja et al, 1997). Plasmids
containing DR-4, RARE (an inverted repeat of consensus se-
quence), and GH-TRE (GH RE) are gifts from Dr Herbert Samuels.
Plasmids containing NCoR and NCoA were a gift from Dr Christ-
opher Glass, a plasmid-containing SMRTwas a gift from Dr Ronald
Evans, a plasmid containing SRC-1 was a gift from Dr Bert
O’Maley and plasmids containing GRIP-1 and GRIP-1 NR box
mutant were a gift from Dr Michael Stallcup. Plasmids were grown
in JM101 Escherichia coli host to saturation density in Luria Broth
medium. DNA was extracted and purified using the Magic Mega
Prep Kit from Promega (San Luis Obispo, California).
Cell growth Normal human foreskin epidermal keratinocytes were
a generous gift from Dr M. Simon. The cultures were initiated using
3T3 feeder layers as described (Randolph and Simon, 1993) and
then frozen in liquid N2 until used. Once thawed, the keratinocytes
were grown without feeder cells in defined serum-free keratinocyte
medium supplemented with epidermal growth factor and bovine
pituitary extract (keratinocyte-SFM, GIBCO, Carlsbad, California).
Cells were expanded through two 1:4 passages before transfection
and transfected at 100% confluency. HeLa cells were maintained
in Dulbeco-modified Eagle’s medium (DMEM) supplemented with
10% calf serum at 371C in a 5% CO2 atmosphere in media con-
taining penicillin and streptomycin as described (Tomic et al, 1990).
The day before transfection, cells were plated onto 60 mm dishes
in low density (10%–15% confluency). Four hours before transfect-
ion, the medium was changed to phenol-red free DMEM supple-
mented with charcoal-pre-treated, depleted 10% calf serum, as
described (Tomic et al, 1990). Preliminary experiments aimed to
establish the effects of co-regulators and their appropriate con-
centration curves were performed initially in HeLa cells and, sub-
sequently, results were confirmed in primary human keratinocytes.
Transfection using Ca2(PO)4 and N,N-bis(2-hydroxyethyl)-2-
aminoethane sulfonic acid (BES) co-precipitation We have
generally followed the published procedures for cells that were at
15%–20% confluence (Chen and Okayama, 1988). At the time of
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transfection, 3–5 mg of the CAT plasmid, 1 mg of the NR expression
vector plasmid, 1 mg pRSVZ reference plasmid, and a sufficient
amount of carrier to bring the total to 10 mg of DNA in each dish
were added. DNA mix was prepared with 50 mL of 2.5 M CaCl2 and
filled up to 500 mL dH2O and subsequently added to the 500 mL of
the BES buffer followed by vigorous shaking. After 10 min of in-
cubation at room temperature, the precipitate mix was aliquoted
to the duplicate plates. After transfection, cells were incubated in
DMEM supplemented with charcoal-pre-treated 10% depleted calf
serum in the presence or absence of 0.1 or 1 mM of dexamethasone
(Sigma, St. Louis, Missouri) in ethanol or T3 (Sigma) in 0.1 N NaOH.
The cells were harvested 48 h after transfection by scraping into
5 mL of phosphate-buffered saline (PBS), washed once more in PBS,
and resuspended in 150 mL of 0.25 M Tris buffer pH 7.8. All transfect-
ions were performed in duplicate plates, and each transfection ex-
periment was repeated two to five times. CAT and b-galactosidase
assay were performed as described (Jiang et al, 1991).
Transfection by polybrene with dimethyl sulfoxide (DMSO)
shock Transfections using polybrene with DMSO shock were
used to transfect the DNA into 100% confluent keratinocytes, as
previously described (Jiang et al, 1991). At the day of transfection,
cells were washed and incubated in the basal medium without EGF
and bovine pituitary extract. Each transfection contained 10–15 mg
per dish of keratin–CAT construct and 3 mg per dish of RSVZ con-
struct. The cells were then incubated with or without 0.1 mM de-
xamethasone (Sigma) dissolved in ethanol or T3 (Sigma) in 0.1 N
NaOH. Forty-eight hours after transfection, cells were washed
twice with PBS and harvested by scraping. The cell disruption by
repeated freeze–thaw cycles, as well as CAT and b-galactosidase
assays have also been described (Jiang et al, 1991).
Use of antisense oligonucleotides We used oligonucleotides
with the sequences CATCTAGAAGAGATTATG for human SMRT
(AS-SMRT), CATTATCAGTAAAGAAGTCC for human NCoR (AS-
NCoR), CATCTTGAACACATATCAGC for human NCoA (AS-NCoA),
and as a control, TGGATCATCTTCTGCCATTCT for NF-kB mRNA.
They were synthesized as phosphorothioates to prolong their half-
lives in the cells. These sequences were designed to bind the in-
itiation codon and the sequences immediately upstream, sites that
commonly confer the most efficient antisense blocking. We fol-
lowed a protocol we successfully used previously (Tomic-Canic
et al, 1992; Radoja et al, 1997). The keratinocytes were incubated
in basal keratinocyte medium (Gibco) without bovine pituitary ex-
tract, EGF, hydrocortisone or thyroid hormone, and HeLa cells
were incubated in 1% delipidized medium from the beginning of
transfection. The antisense DNA were added to the transfected
DNA mixture and subsequently to the medium of the cells
transfected with the GR-responsive CAT constructs. Including
the antisense DNA in the transfection mix has the advantage of
ensuring that the cells that received the transfected DNA also
received the antisense oligonucleotides. We added 5 mM
concentrations of the oligonucleotides to the medium immediately
after transfection and again 18 h later. Cells were harvested 36 h
after transfection, and enzyme assays were performed.
Enzyme assays Briefly, the substrate solution contained 6 mg of
O-nitrophenyl-D-galactoside (Sigma) freshly dissolved in PM buffer
(66 mM Na2HPO4, 33 mM NaH2PO4, 40 mM mercaptoethanol, 2
mM MgSO4, and 0.1 mM MnCl2). The reaction mixture contained
100 mL of substrate solution, 300 mL of PM buffer, and 50 mL of
keratinocyte cell extract or 20–30 mL of HeLa cell extract. It was
incubated at 371C until development of yellow color was obvious,
usually 10–30 min. The time of the reaction was recorded and the
reaction stopped by addition of 0.4 mL of 1 M Na2CO3. OD420 was
measured on a spectrophotometer (Gilford, Oberlin, Ohio).
The CAT reaction mixture contained 69 mL of 1 M Tris HCl, pH
7.8, 1 mL of 14[C]-chloramphenicol (Cm, 40–50 mCi per mMole,
New England Nuclear, Boston Massachusetts), 20 mL of 4 mM
acetyl-CoA solution, 30–60 mL of cell extract, and enough water to
bring the total reaction volume to 150 mL. After incubation at 371C
for 30 min, the mixture was extracted into 1 mL of ethylacetate,
phases were separated by brief centrifugation, the organic layer was
transferred to a new tube, and the solvent evaporated. The residue
was dissolved in 30 mL of ethyl acetate and separated by thin-layer
chromatography on silica gel in chloroform:methanol¼ 95:5. The
plates were exposed to X-ray film for 12–24 h, and the intensity of
radioactive spots determined using the Ambis Radioanalytic System
(Ambis, San Diego, California). The conversion of chloramphenicol
to its monoacetylated derivative was kept below 50% by varying the
amount of extract or the duration of the reaction.
All CAT values were normalized for transfection efficiency by
calculating the ratio of CAT activity to b-galactosidase in each
transfected plate. Each transfection experiment was separately
performed three or more times, with each data point resulting from
duplicate or triplicate transfections.
Northern blot Primary human keratinocytes were transfected
with expression vectors for GRIP-1, T3R, and RAR, as described
above. The cells were incubated in the presence or absence of
corresponding ligands, 0.1 mM of either T3 or RA, and harvested 48
h later. Similarly, for the TSA experiment, cells were incubated in
the presence or absence of 0.1 mM TSA and corresponding
hormones. RNA isolation and purification was performed using
Triazol (Invitrogen, Carlsbad, California) extraction and subse-
quently Quiagen RNeasy Kit column purification (Qiagen, Valencia,
California) followed by northern blot as described (Radoja et al,
2000). K14 and glyceraldehyde-3-phosphate dehydrogenase
probes were generated as described (Radoja et al, 2000).
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